News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
238,779 Results
Type
Article (9628)
Company Profile (17)
Press Release (229134)
Multimedia
Podcasts (9)
Webinars (1)
Section
Business (62833)
Career Advice (928)
Deals (13373)
Drug Delivery (20)
Drug Development (29409)
Employer Resources (28)
FDA (7812)
Job Trends (4847)
News (118512)
Policy (15666)
Tag
Academia (735)
Accelerated approval (2)
Adcomms (16)
Allergies (45)
Alliances (17993)
ALS (47)
Alzheimer's disease (537)
Antibody-drug conjugate (ADC) (56)
Approvals (7804)
Artificial intelligence (130)
Autoimmune disease (9)
Automation (8)
Bankruptcy (95)
Best Places to Work (4321)
Biosimilars (34)
Biotechnology (23)
Bladder cancer (42)
Brain cancer (15)
Breast cancer (120)
Cancer (1016)
Cardiovascular disease (77)
Career advice (740)
Career pathing (8)
CAR-T (65)
Cell therapy (189)
Cervical cancer (9)
Clinical research (24309)
Collaboration (375)
Compensation (324)
Complete response letters (28)
COVID-19 (828)
CRISPR (26)
C-suite (72)
Cystic fibrosis (42)
Data (1036)
Denatured (3)
Depression (17)
Diabetes (103)
Diagnostics (2608)
Digital health (8)
Diversity (1)
Diversity, equity & inclusion (6)
Drug discovery (51)
Drug pricing (10)
Drug shortages (2)
Duchenne muscular dystrophy (39)
Earnings (29179)
Editorial (2)
Employer branding (3)
Employer resources (22)
Events (27299)
Executive appointments (226)
FDA (8616)
Frontotemporal dementia (4)
Funding (328)
Gene editing (61)
Generative AI (13)
Gene therapy (118)
GLP-1 (206)
Government (1339)
Grass and pollen (1)
Guidances (59)
Healthcare (5645)
Huntington's disease (9)
IgA nephropathy (11)
Immunology and inflammation (45)
Indications (20)
Infectious disease (889)
Inflammatory bowel disease (72)
Influenza (20)
Intellectual property (67)
Interviews (205)
IPO (7120)
IRA (5)
Job creations (688)
Job search strategy (578)
Kidney cancer (3)
Labor market (17)
Layoffs (120)
Leadership (3)
Legal (2109)
Liver cancer (35)
Lung cancer (156)
Lymphoma (66)
Machine learning (5)
Management (6)
Manufacturing (114)
MASH (34)
Medical device (5212)
Medtech (5213)
Mergers & acquisitions (6601)
Metabolic disorders (215)
Multiple sclerosis (45)
NASH (6)
Neurodegenerative disease (43)
Neuropsychiatric disorders (12)
Neuroscience (776)
NextGen: Class of 2025 (1756)
Non-profit (721)
Now hiring (6)
Obesity (85)
Opinion (65)
Ovarian cancer (29)
Pain (46)
Pancreatic cancer (38)
Parkinson's disease (50)
Partnered (14)
Patents (160)
Patient recruitment (45)
Peanut (26)
People (14196)
Pharmaceutical (5)
Pharmacy benefit managers (1)
Phase I (6975)
Phase II (9732)
Phase III (10072)
Pipeline (738)
Policy (22)
Postmarket research (532)
Preclinical (3145)
Press Release (44)
Prostate cancer (50)
Psychedelics (19)
Radiopharmaceuticals (119)
Rare diseases (189)
Real estate (1216)
Recruiting (13)
Regulatory (13396)
Reports (25)
Research institute (608)
Resumes & cover letters (241)
Rett syndrome (3)
RNA editing (3)
RSV (13)
Schizophrenia (28)
Series A (52)
Series B (29)
Service/supplier (2)
Sickle cell disease (13)
Special edition (6)
Spinal muscular atrophy (68)
Sponsored (10)
Startups (972)
State (1)
Stomach cancer (5)
Supply chain (21)
Tariffs (5)
The Weekly (6)
Vaccines (197)
Venture capitalists (11)
Weight loss (39)
Women's health (11)
Worklife (2)
Date
Today (121)
Last 7 days (378)
Last 30 days (1274)
Last 365 days (14315)
2025 (4986)
2024 (15388)
2023 (17419)
2022 (23681)
2021 (23502)
2020 (20858)
2019 (15780)
2018 (11510)
2017 (12119)
2016 (10378)
2015 (12252)
2014 (8552)
2013 (7358)
2012 (8136)
2011 (8586)
2010 (7573)
Location
Africa (186)
Alabama (38)
Alaska (1)
Arizona (37)
Arkansas (1)
Asia (15362)
Australia (2713)
California (2603)
Canada (1337)
China (290)
Colorado (109)
Connecticut (134)
Delaware (58)
Europe (32847)
Florida (439)
Georgia (127)
Idaho (16)
Illinois (190)
India (10)
Indiana (107)
Iowa (5)
Japan (78)
Kansas (42)
Kentucky (4)
Maine (29)
Maryland (329)
Massachusetts (1742)
Michigan (95)
Minnesota (121)
Missouri (23)
Montana (7)
Nebraska (7)
Nevada (21)
New Hampshire (27)
New Jersey (809)
New Mexico (18)
New York (867)
North Carolina (368)
North Dakota (6)
Northern California (1170)
Ohio (72)
Oregon (2)
Pennsylvania (583)
Puerto Rico (8)
Rhode Island (16)
South America (344)
South Carolina (6)
Southern California (987)
Tennessee (24)
Texas (401)
United States (9665)
Utah (95)
Virginia (48)
Washington D.C. (15)
Washington State (221)
West Virginia (2)
Wisconsin (21)
238,779 Results for "ion beam applications iba".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
IBA launches myQA Blue Phantom³ for radiation therapy quality assurance
May 5, 2025
·
2 min read
Gene editing
Beam’s Gene Editor Achieves ‘First Ever’ Genetic Correction in AATD
BEAM-302 “has set the bar for efficacy in this space,” William Blair analysts wrote in an investor note on Monday.
March 11, 2025
·
2 min read
·
Tristan Manalac
Gene editing
‘Safer’ CRISPR: Base Editing Breaks Through in the Clinic as Beam, Verve Advance
Beam Therapeutics and Verve Therapeutics have each built their lead candidates on a technique billed as a safer alternative to conventional CRISPR. Clinical results have so far been promising.
May 5, 2025
·
9 min read
·
Shawna Williams
Press Releases
IBA long-term strategy presented at 2025 Capital Markets Day
April 8, 2025
·
2 min read
Press Releases
IBA to share long-term growth strategy at upcoming 2025 Capital Markets Day
April 4, 2025
·
1 min read
Press Releases
IBA reports solid Full Year 2024 results
March 20, 2025
·
4 min read
Press Releases
IBA signs contract for a Proteus®ONE solution to be installed at the Tri-Service General Hospital in Taiwan
April 2, 2025
·
3 min read
Press Releases
IBA Notice of Full Year 2024 Results and Conference Call
February 27, 2025
·
1 min read
Press Releases
IBA and Apollo Hospitals sign a term sheet for one Proteus®ONE system plus a second one in option to be installed in India
March 4, 2025
·
3 min read
Centre for Ion Beam Applications at NUS designated as IAEA’s first Collaborating Centre in Singapore
The Centre for Ion Beam Applications (CIBA), a multidisciplinary research centre at the National University of Singapore (NUS), has recently been designated as an International Atomic Energy Agency (IAEA) Collaborating Centre for Research and Development of Accelerator Science and Multidisciplinary Applications.
September 20, 2023
·
8 min read
1 of 23,878
Next